血清淀粉樣P物質(zhì)(SAP)單克隆抗體
Monoclonal Antibody to Serum Amyloid P Component (SAP)
APCS; PTX2; Pentaxin-Related; 9.5S Alpha-1-Glycoprotein
- 編號UMAB539Hu25
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(jià)(克隆號)-
- Ig亞型 IgG
- 純化方式蛋白A + 蛋白G親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原 RPB539Hu01-血清淀粉樣P物質(zhì)(SAP)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度1mg/ml
- 且適物種-
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細(xì)胞術(shù)，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價(jià)格 ¥ 323 ¥ 754 ¥ 1077 ¥ 2693 ¥ 10770
- 欲了解實(shí)際交易價(jià)格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對SAP的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識別SAP。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
抗體標(biāo)記定制服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽性對照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
長臂生物素標(biāo)記試劑盒
實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| URPB539Hu01 | 血清淀粉樣P物質(zhì)(SAP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPB539Hu02 | 血清淀粉樣P物質(zhì)(SAP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAB539Hu01 | 血清淀粉樣P物質(zhì)(SAP)多克隆抗體 | WB; IHC |
| UPAB539Hu02 | 血清淀粉樣P物質(zhì)(SAP)多克隆抗體 | WB; IHC |
| ULAB539Hu81 | 血清淀粉樣P物質(zhì)(SAP)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| ULAB539Hu71 | 血清淀粉樣P物質(zhì)(SAP)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| UMAB539Hu22 | 血清淀粉樣P物質(zhì)(SAP)單克隆抗體 | IHC |
| UMAB539Hu23 | 血清淀粉樣P物質(zhì)(SAP)單克隆抗體 | WB; IHC; ICC; IP. |
| UMAB539Hu24 | 血清淀粉樣P物質(zhì)(SAP)單克隆抗體 | WB; IHC; ICC; IP. |
| UMAB539Hu25 | 血清淀粉樣P物質(zhì)(SAP)單克隆抗體 | WB; IHC; ICC; IP. |
| UMAB539Hu21 | 血清淀粉樣P物質(zhì)(SAP)單克隆抗體 | IHC |
| USEB539Hu | 血清淀粉樣P物質(zhì)(SAP)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| USCB539Hu | 血清淀粉樣P物質(zhì)(SAP)檢測試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| ULMB539Hu | 血清淀粉樣P物質(zhì)(SAP)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Journal of Vascular Surgery | Circulation levels of acute phase proteins in patients with Takayasu arteritis [PubMed: 20100644] |
| Journal of Proteome Research | Combined Proteomic and Metabolomic Profiling of Serum Reveals Association of the Complement System with Obesity and Identifies Novel Markers of Body Fat Mass Changes [ACS: pr2005555] |
| Liver International | Identification of candidate biomarkers for hepatocellular carcinoma in plasma of HCV-infected cirrhotic patients by 3-D DIGE [Pubmed: 23944848] |
| Journal of Proteome Research | Targeted proteomics predict a sustained complete-response after transarterial chemoembolization and clinical outcomes in patients with hepatocellular carcinoma: a prospective cohort study [pubmed:28112944] |
| American Journal of Reproductive Immunology | Amniotic fluid pentraxins: Potential early markers for identifying intra‐amniotic inflammatory complications in preterm pre‐labor rupture of membranes [pubmed:29193454] |
| Theranostics | Serum amyloid P component therapeutically attenuates atherosclerosis in mice via its effects on macrophages [Pubmed:29930724] |
| J Med Primatol | Proteopathic lesions in the brain of a super?\aged chimpanzee (Pan troglodytes) [34096618] |
| Clinical and Experimental Immunology | Clinical significance of differential serum-signatures for early prediction of severe dengue among Eastern Indian patients [Pubmed:35348620] |
